New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 11, 2012
10:24 EDTCSIICardiovascular Systems presents CONFIRM series data at VIVA 2012
Data presented yesterday from Cardiovascular Systems’ CONFIRM study series demonstrate that CSI’s minimally invasive orbital atherectomy system is an effective treatment for peripheral arterial disease. CSI’s technology protects healthy vessel tissue while removing even the most difficult-to-treat plaque throughout the leg with fewer complications. The study titled “Procedural Effectiveness of Orbital Technology in More Than 3,100 Patients with Infra-inguinal Disease: Results from the CONFIRM Series” was part of a late-breaking presentation at the 2012 Vascular Interventional Advances conference.
News For CSII From The Last 14 Days
Check below for free stories on CSII the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CSII

Sign up for a free trial to see the rest of the stories you've been missing.